Literature DB >> 15166498

Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma.

Oddbjørn Straume1, Lars A Akslen.   

Abstract

Glomeruloid microvascular proliferations (GMPs), which are focal proliferative buddings of endothelial cells resembling a renal glomerulus, can be induced experimentally by adenoviral transfer of VEGF-A(165). We recently found that GMPs were present in 13-23% of various human tumours (melanoma, breast-, endometrial- and prostate cancer), and this vascular signature was significantly associated with an impaired prognosis. In the present study, a series of 202 vertical growth phase melanomas were examined for the expression of various angiogenic factors and their receptors. Presence of GMP was associated with increased expression in tumour endothelium of the VEGF-A receptors KDR, FLT-1 and neuropilin-1, as well as VEGF-D protein. Thrombospondin-1 staining in the tumour stroma showed the same relationship. Endothelial cell expression of VEGF-A was increased in GMP endothelium when compared with other intra-tumoural vessels. In contrast, GMP expression of bFGF was decreased. Our findings suggest an important role of VEGF-A and its receptors in GMP formation in human cutaneous melanoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15166498     DOI: 10.1023/B:AGEN.0000029408.08638.aa

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  17 in total

1.  Ultrasound molecular imaging of tumor angiogenesis with a neuropilin-1-targeted microbubble.

Authors:  Hua Zhang; Sarah Tam; Elizabeth S Ingham; Lisa M Mahakian; Chun-Yen Lai; Spencer K Tumbale; Tambet Teesalu; Neil E Hubbard; Alexander D Borowsky; Katherine W Ferrara
Journal:  Biomaterials       Date:  2015-04-16       Impact factor: 12.479

Review 2.  Vascular endothelial growth factor receptor-2 in breast cancer.

Authors:  Shanchun Guo; Laronna S Colbert; Miles Fuller; Yuanyuan Zhang; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-05-11

Review 3.  Neuropilins: expression and roles in the epithelium.

Authors:  Jonathan R L Wild; Carolyn A Staton; Keith Chapple; Bernard M Corfe
Journal:  Int J Exp Pathol       Date:  2012-04       Impact factor: 1.925

4.  Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis.

Authors:  Xiao-Yong Man; Xiao-Hong Yang; Sui-Qing Cai; Yong-Gang Yao; Min Zheng
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

5.  Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes.

Authors:  Eric E Paoli; Elizabeth S Ingham; Hua Zhang; Lisa M Mahakian; Brett Z Fite; M Karen Gagnon; Sarah Tam; Azadeh Kheirolomoom; Robert D Cardiff; Katherine W Ferrara
Journal:  J Control Release       Date:  2014-01-13       Impact factor: 9.776

Review 6.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

Review 7.  Transcriptional targeting of tumor endothelial cells for gene therapy.

Authors:  Zhihong Dong; Jacques E Nör
Journal:  Adv Drug Deliv Rev       Date:  2009-04-23       Impact factor: 15.470

Review 8.  VEGF targets the tumour cell.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Nat Rev Cancer       Date:  2013-12       Impact factor: 60.716

9.  Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.

Authors:  Cornelia Schuster; Hans P Eikesdal; Hanne Puntervoll; Jürgen Geisler; Stephanie Geisler; Daniel Heinrich; Anders Molven; Per E Lønning; Lars A Akslen; Oddbjørn Straume
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

10.  Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.

Authors:  Wiebke Hansen; Marina Hutzler; Simone Abel; Christina Alter; Christian Stockmann; Stefanie Kliche; Juliane Albert; Tim Sparwasser; Shimon Sakaguchi; Astrid M Westendorf; Dirk Schadendorf; Jan Buer; Iris Helfrich
Journal:  J Exp Med       Date:  2012-10-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.